Pediatrics international : official journal of the Japan Pediatric Society · 2026
High-Flow Nasal Cannula Versus Conventional Therapy After Slide Tracheoplasty.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Uematsu Ayano, Morita Keiichi, Hatakeyama Tadashi, Aoki Kazunori, Kurosawa Hiroshi, Bitoh Yuko
Аннотация
BACKGROUND: Few studies have focused on the respiratory management after slide tracheoplasty. This study aimed to evaluate the effect of high-flow nasal cannula (HFNC) compared with conventional therapy in preventing reintubation after slide tracheoplasty.
METHODS: This was a retrospective study conducted at a single center, the Department of Pediatric Surgery. The medical records of 68 patients who had undergone slide tracheoplasty for congenital tracheal stenosis (CTS) before the age of 2 years from February 2012 to September 2021 were included. Patients were divided into group C (conventional therapy) or H (HFNC therapy), based on whether conventional oxygen therapy and positive pressure ventilation or HFNC was used after withdrawal from the ventilator, respectively.
RESULTS: There were no significant differences in the postoperative reintubation rate and ventilator dependency between groups C and H. There were no HFNC complications.
CONCLUSIONS: The use of postoperative HFNC is not inferior to noninvasive ventilation in terms of therapeutic efficacy. HFNC can be used without complications for a limited time after extubation.
METHODS: This was a retrospective study conducted at a single center, the Department of Pediatric Surgery. The medical records of 68 patients who had undergone slide tracheoplasty for congenital tracheal stenosis (CTS) before the age of 2 years from February 2012 to September 2021 were included. Patients were divided into group C (conventional therapy) or H (HFNC therapy), based on whether conventional oxygen therapy and positive pressure ventilation or HFNC was used after withdrawal from the ventilator, respectively.
RESULTS: There were no significant differences in the postoperative reintubation rate and ventilator dependency between groups C and H. There were no HFNC complications.
CONCLUSIONS: The use of postoperative HFNC is not inferior to noninvasive ventilation in terms of therapeutic efficacy. HFNC can be used without complications for a limited time after extubation.